Elite Pharmaceuticals, Inc. (ELTP)
USD 0.4
(-2.88%)
USD 0.4
(-2.88%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 56.62 Million | 34.15 Billion | 32.26 Million | 25.38 Million | 17.99 Million | 7.56 Million |
| Cost of Revenue | 31.64 Million | 17.56 Billion | 17.46 Million | 13.51 Million | 10.01 Million | 4.7 Million |
| Gross Profit | 24.97 Million | 16.59 Billion | 14.79 Million | 11.86 Million | 7.97 Million | 2.86 Million |
| Operating Expenses | 14.18 Million | 12.91 Billion | 9.72 Million | 9.76 Million | 10.26 Million | 12.02 Million |
| Selling, General and Administrative Expenses | 7.3 Million | 5.12 Billion | 4.47 Million | 3.33 Million | 3.41 Million | 3.21 Million |
| Research and Development Expenses | 6.88 Million | 6.2 Billion | 4.05 Million | 5.11 Million | 5.53 Million | 7.59 Million |
| Other Expenses | - | 1.59 Billion | 1.19 Million | 1.31 Million | 1.31 Million | 1.2 Million |
| Cost and Expenses | 45.83 Million | 30.47 Billion | 27.19 Million | 23.27 Million | 20.28 Million | 16.72 Million |
| Operating Income | 10.78 Million | 2.02 Billion | 5.07 Million | 2.1 Million | -2.28 Million | -9.15 Million |
| Interest Expense | 588.62 Thousand | 1.11 Million | 191.81 Thousand | 259.59 Thousand | 355.87 Thousand | 369.17 Thousand |
| Income Tax Expense | -19.64 Million | -424.02 Million | -1.73 Million | -943.9 Thousand | 2000.00 | -427.46 Thousand |
| Earnings before Tax | 463.09 Thousand | 3.98 Billion | 6.3 Million | 4.14 Million | -2.23 Million | -9.95 Million |
| Net Income | 20.1 Million | 4.4 Billion | 8.89 Million | 5.08 Million | -2.24 Million | -9.27 Million |
| Earnings Per Share Basic | 0.02 | 4.35 | 0.01 | 0.01 | -0.00 | -0.01 |
| Earnings Per Share Diluted | 0.02 | 4.35 | 0.01 | 0.01 | -0.00 | -0.01 |
| Weighted Average Shares Outstanding | 1.01 Billion | 1.01 Billion | 1.01 Billion | 942.99 Million | 832.32 Million | 814.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.02 Billion | 1.01 Billion | 1.01 Billion | 942.99 Million | 832.32 Million | 816.31 Million |
| Gross Margin | 0.44 | 0.49 | 0.46 | 0.47 | 0.44 | 0.38 |
| EBIT Margin | 0.21 | 0.10 | 0.20 | 0.14 | -0.04 | -1.04 |
| Profit Margin | 0.36 | 0.13 | 0.28 | 0.20 | -0.12 | -1.23 |
| EBITDA | 12.1 Million | 6.42 Million | 6.26 Million | 5.92 Million | -371.87 Thousand | -8.34 Million |
| Earnings Before Tax Margin | 0.19 | 0.06 | 0.16 | 0.08 | -0.13 | -1.21 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 17.94 Million | 56.62 Million | 15.53 Million | 14.15 Million | 8.98 Million | 34.15 Billion |
| Cost of Revenue | 10.21 Million | 31.64 Million | 8.84 Million | 7.71 Million | 4.22 Million | 17.56 Billion |
| Gross Profit | 7.73 Million | 24.97 Million | 6.69 Million | 6.44 Million | 4.75 Million | 16.59 Billion |
| Operating Expenses | 4 Million | 14.18 Million | 3.16 Million | 4.52 Million | 3.14 Million | 12.91 Billion |
| Selling, General and Administrative Expenses | 2.29 Million | - | 1.76 Million | 1.57 Million | 1.67 Million | - |
| Research and Development Expenses | 1.71 Million | - | 1.4 Million | 2.61 Million | 1.14 Million | - |
| Other Expenses | -822.09 Thousand | -5.74 Million | -2.85 Million | -2.06 Million | 343.28 Thousand | 1.59 Billion |
| Cost and Expenses | 14.22 Million | 45.83 Million | 12 Million | 12.23 Million | 7.37 Million | 30.47 Billion |
| Operating Income | 3.72 Million | 10.78 Million | 3.53 Million | 1.92 Million | 1.6 Million | 2.02 Billion |
| Interest Expense | 217.14 Thousand | 588.62 Thousand | 121.62 Thousand | 130.43 Thousand | 119.41 Thousand | -1.11 Billion |
| Income Tax Expense | -1.33 Million | -19.64 Million | -800.61 Thousand | -17.66 Million | 154.95 Thousand | -424.02 Million |
| Earnings before Tax | 1.99 Million | 463.09 Thousand | -94.25 Thousand | -2.73 Million | 1.29 Million | 3.98 Billion |
| Net Income | 3.32 Million | 20.1 Million | 706.35 Thousand | 14.93 Million | 1.14 Million | 4.4 Billion |
| Earnings Per Share Basic | 0.00 | - | 0.00 | 0.01 | 0.00 | - |
| Earnings Per Share Diluted | 0.00 | - | 0.00 | 0.01 | 0.00 | - |
| Weighted Average Shares Outstanding | 1.02 Billion | 1.01 Billion | 1.01 Billion | 1.01 Billion | 1.01 Billion | 1.01 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.04 Billion | 1.02 Billion | 1.02 Billion | 1.01 Billion | 1.01 Billion | 1.01 Billion |
| Gross Margin | 0.43 | 0.44 | 0.43 | 0.46 | 0.53 | 0.49 |
| EBIT Margin | 0.24 | - | 0.25 | 0.16 | 0.22 | - |
| Profit Margin | 0.19 | 0.36 | 0.05 | 1.05 | 0.13 | 0.13 |
| EBITDA | 4.24 Million | - | 3.88 Million | 2.26 Million | 1.94 Million | - |
| Earnings Before Tax Margin | 0.21 | 0.19 | 0.23 | 0.14 | 0.18 | 0.06 |
DEEPAKNTR
5211
6859
UMESLTD
FGPHF
3701